{
    "nct_id": "NCT04454229",
    "official_title": "The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge - An International Multicenter Randomized Control Trial - The PALACE Study",
    "inclusion_criteria": "1. Adult patients referred to the outpatient allergy clinic for a penicillin allergy history;\n2. Willing and able to give consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Patient age is < 18 years;\n2. Patients with a PEN-FAST score less than 3\n3. Pregnancy;\n4. Any other illness that, in the investigator's judgement, will substantially increase the risk associated with subject's participation in this study;\n5. Patients with history of type A adverse drug reaction, drug-associated anaphylaxis, idiopathic urticaria/anaphylaxis, mastocytosis, serum sickness, blistering skin eruption or acute interstitial nephritis;\n6. Patients where the allergy history was not able to be confirmed with patient;\n7. Patients on concurrent antihistamine therapy;\n8. Patients receiving more than stress dose steroids (i.e. > 50mg QID hydrocortisone [or steroid equivalent]).",
    "miscellaneous_criteria": ""
}